Astellas Pharma Inc. (TYO:4503)
Japan
· Delayed Price · Currency is JPY 2,306.00
-79.50 (-3.33%)
Apr 28, 2026, 3:30 PM JST
Astellas Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Net Income | 291,535 | 31,237 | 24,969 | 132,361 | 156,886 | Upgrade
|
| Depreciation & Amortization | 194,594 | 199,132 | 157,840 | 105,738 | 79,684 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 187,564 | 78,931 | 84,499 | 74,850 | Upgrade
|
| Asset Writedown & Restructuring Costs | 54,187 | - | - | - | - | Upgrade
|
| Other Operating Activities | 56,857 | -75,674 | -37,563 | -68,811 | -43,293 | Upgrade
|
| Change in Accounts Receivable | -63,794 | -104,735 | -55,948 | -4,849 | -8,001 | Upgrade
|
| Change in Inventory | -16,218 | -50,225 | -60,036 | -7,086 | 24,058 | Upgrade
|
| Change in Accounts Payable | -307 | -11,409 | 29,466 | -12,274 | -10,101 | Upgrade
|
| Change in Other Net Operating Assets | 43,334 | 18,622 | 34,816 | 98,189 | -16,639 | Upgrade
|
| Operating Cash Flow | 560,188 | 194,512 | 172,475 | 327,767 | 257,444 | Upgrade
|
| Operating Cash Flow Growth | 188.00% | 12.78% | -47.38% | 27.32% | -16.10% | Upgrade
|
| Capital Expenditures | -57,723 | -37,003 | -38,056 | -36,441 | -30,739 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 441 | Upgrade
|
| Cash Acquisitions | - | - | -784,974 | - | -670 | Upgrade
|
| Sale (Purchase) of Intangibles | -26,922 | -19,168 | -33,438 | -51,888 | -21,428 | Upgrade
|
| Investment in Securities | - | 12,920 | - | 12,624 | - | Upgrade
|
| Other Investing Activities | 17,923 | -46,168 | 10,666 | -8,795 | -10,017 | Upgrade
|
| Investing Cash Flow | -66,722 | -89,419 | -845,802 | -84,500 | -62,413 | Upgrade
|
| Short-Term Debt Issued | - | - | 324,337 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 200,000 | 472,275 | 50,000 | - | Upgrade
|
| Total Debt Issued | - | 200,000 | 796,612 | 50,000 | - | Upgrade
|
| Short-Term Debt Repaid | -185,625 | -236,449 | - | -15,000 | - | Upgrade
|
| Long-Term Debt Repaid | -97,269 | -52,073 | -25,379 | -50,000 | -60,000 | Upgrade
|
| Total Debt Repaid | -282,894 | -288,522 | -25,379 | -65,000 | -60,000 | Upgrade
|
| Net Debt Issued (Repaid) | -282,894 | -88,522 | 771,233 | -15,000 | -60,000 | Upgrade
|
| Repurchase of Common Stock | -730 | -6,960 | -10,735 | -60,556 | -50,717 | Upgrade
|
| Common Dividends Paid | -136,099 | -128,993 | -116,653 | -100,355 | -85,236 | Upgrade
|
| Other Financing Activities | 14,944 | -36,892 | -29,785 | -19,712 | -20,345 | Upgrade
|
| Financing Cash Flow | -404,779 | -261,367 | 614,060 | -195,623 | -216,298 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4,547 | 8,960 | 18,113 | 13,210 | 11,125 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -1 | -1 | 1 | - | -1 | Upgrade
|
| Net Cash Flow | 93,233 | -147,315 | -41,153 | 60,854 | -10,143 | Upgrade
|
| Free Cash Flow | 502,465 | 157,509 | 134,419 | 291,326 | 226,705 | Upgrade
|
| Free Cash Flow Growth | 219.01% | 17.18% | -53.86% | 28.50% | -17.70% | Upgrade
|
| Free Cash Flow Margin | 23.49% | 8.24% | 8.38% | 19.18% | 17.49% | Upgrade
|
| Free Cash Flow Per Share | 279.60 | 87.64 | 74.69 | 159.63 | 122.50 | Upgrade
|
| Cash Income Tax Paid | 98,612 | 85,478 | 38,112 | 69,479 | 42,093 | Upgrade
|
| Levered Free Cash Flow | 388,721 | 125,260 | 134,671 | 202,242 | 174,913 | Upgrade
|
| Unlevered Free Cash Flow | 397,516 | 133,980 | 139,311 | 204,253 | 176,360 | Upgrade
|
| Change in Working Capital | -36,985 | -147,747 | -51,702 | 73,980 | -10,683 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.